KARAMBIOSCIENCE
EST. 2026
EVIDENCE / 02
A cinematic molecular-and-climate scene with a CRISPR complex, cells and a planet.
CRISPR Atlas / External evidence
Primary human cells

Primary myeloid screens reveal context-specific inflammatory effects

Virus-like particle tools enabled targeted engineering and pooled screening of primary human myeloid cells. In the macrophage context highlighted in the assessment, disrupting TNFAIP3 promoted inflammation.

Concept illustration / not experimental evidence

What was reported

Virus-like particle tools enabled targeted engineering and pooled screening of primary human myeloid cells. In the macrophage context highlighted in the assessment, disrupting TNFAIP3 promoted inflammation. [C08]

What the result does not establish

A gene name is not an intervention recommendation. An effect can have the opposite direction from what another cell type or disease context might suggest.

Measured endpoint

Editing feasibility and regulators of inflammatory polarization.

Karam’s next question

Can a partner connect a defined perturbation to specialized immune function rather than generic proliferation?

Assessment-derived brief. Cited in the supplied 15 October 2026 project assessment; not independently reviewed in this website release. Karam has not reproduced the experiment or independently audited the underlying dataset. This is not Karam-generated evidence.

Record transparency

The details—and the missing values.

Extraction scope: supplied project assessment, not an independent full-methods extraction
Study date2026-08-17
Reported regionNot assigned
Species / biological systemHuman
Target / subjectTNFAIP3 and other regulators
Cell or population contextMonocytes, macrophages and dendritic cells
Perturbation directionDisruption; context-dependent inflammation
MethodCas9 screen
Delivery settingVirus-like particles
ComparatorNot extracted in the supplied assessment; review the primary source before using this field.
Donor contextNot extracted in the supplied assessment; review the primary source before using this field.
Sample size / unitNot extracted in the supplied assessment; review the primary source before using this field.
Follow-upNot extracted in the supplied assessment; review the primary source before using this field.
Safety measurementsNot extracted in the supplied assessment; review the primary source before using this field.
Independent replicationNot established in the supplied assessment
Data accessNot extracted in the supplied assessment; review the primary source before using this field.

What would this evidence change?

Use the context in this record to define a bounded research or diligence question. A cited finding is not a validated Karam asset.